ADAR1 Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

ADAR1 Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Hold	11,701	–	–	0.15%	123
2026 Q1	$3.47M	Buy	+11,701	New	+$3.79M	0.2%	99
2025 Q1	–	Sell	-2,974	Closed	-$549K	–	257
2024 Q4	$549K	Buy	2,974 +1,996	+204%	+$408K	0.11%	108
2024 Q3	$220K	Sell	978 -10,122	-91%	-$1.82M	0.04%	157
2024 Q2	$1.58M	Sell	11,100 -20,405	-65%	-$3.14M	0.3%	52
2024 Q1	$4.93M	Buy	31,505 +29,477	+1,454%	+$4.75M	1.12%	15
2023 Q4	$366K	Buy	+2,028	New	+$367K	0.13%	69

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ADAR1 Capital Management's ONC Position: Q2 2026 in Review

ADAR1 Capital Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 11,701 shares worth $3.33M. The position accounts for 0.15% of the portfolio, ranked #123.

ADAR1 Capital Management first reported a position in ONC in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.93M in Q1 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

ADAR1 Capital Management held 11,701 shares of BeOne Medicines Ltd worth $3.33M as of Q2 2026.
ADAR1 Capital Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up 0.15% of ADAR1 Capital Management's portfolio in Q2 2026, its #123 holding.
ADAR1 Capital Management first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 7 quarters since.
ADAR1 Capital Management's BeOne Medicines Ltd position peaked at $4.93M in Q1 2024.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.